Physician Assistant in Martins Ferry, OH Accepting Medicare

5 Physician Assistant nurses found. Showing 1 - 5

Margie M. Hodge, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 90 N 4th St, Martins Ferry, OH 43935 Phone: 740-633-4544    Fax: 740-633-4493

Alexandra Kaitlyn Tennant, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 90 N 4th St, Martins Ferry, OH 43935 Phone: 740-633-4303    Fax: 740-633-4774

Elizabeth Lynn Snyder, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 90 N 4th St, Martins Ferry, OH 43935 Phone: 740-633-4199    Fax: 740-633-4728

Heather M Shields, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 92 N 4th St Ste 26, Martins Ferry, OH 43935 Phone: 740-633-4360    Fax: 740-633-4361

Jennifer Myers, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 90 N 4th St Ste B, Martins Ferry, OH 43935 Phone: 740-633-4480    Fax: 740-633-4485

News Archive

Experts at ICAO warn about risk of cardiometabolic consequences in overweight individuals

Experts meeting at the 2nd International Congress on Abdominal Obesity today issued a warning that millions of individuals around the globe are at risk from the cardiometabolic consequences of being overweight. Worryingly, the experts suggest that these people are not being identified by their doctors.

Article describes predictors of post-TBI psychiatric disorders

A history of psychiatric illness such as depression or anxiety before a traumatic brain injury (TBI), together with other risk factors, are strongly predictive of post-TBI psychiatric disorders, according to an article published in Journal of Neurotrauma, a peer-reviewed journal published by Mary Ann Liebert, Inc.

ODAC to review Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. (CTI) announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) will review the New Drug Application (NDA) for pixantrone for the treatment of relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL).

Report says cancer clinicians should understand and consider the economic impact of new interventions

Cancer clinicians should understand and consider the economic impact of new interventions, which often have substantial costs, according to a report appearing in the July/August issue of CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society.

Read more Medical News

› Verified 7 days ago